2-Amino-6-methylbenzothiazoleCAS# 2536-91-6 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 2536-91-6 | SDF | Download SDF |
PubChem ID | 17335 | Appearance | Powder |
Formula | C8H8N2S | M.Wt | 164 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 6-methyl-1,3-benzothiazol-2-amine | ||
SMILES | CC1=CC2=C(C=C1)N=C(S2)N | ||
Standard InChIKey | DZWTXWPRWRLHIL-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C8H8N2S/c1-5-2-3-6-7(4-5)11-8(9)10-6/h2-4H,1H3,(H2,9,10) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
2-Amino-6-methylbenzothiazole Dilution Calculator
2-Amino-6-methylbenzothiazole Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 6.0976 mL | 30.4878 mL | 60.9756 mL | 121.9512 mL | 152.439 mL |
5 mM | 1.2195 mL | 6.0976 mL | 12.1951 mL | 24.3902 mL | 30.4878 mL |
10 mM | 0.6098 mL | 3.0488 mL | 6.0976 mL | 12.1951 mL | 15.2439 mL |
50 mM | 0.122 mL | 0.6098 mL | 1.2195 mL | 2.439 mL | 3.0488 mL |
100 mM | 0.061 mL | 0.3049 mL | 0.6098 mL | 1.2195 mL | 1.5244 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 16-O-Acetylpolyporenic acid C
Catalog No.:BCN4058
CAS No.:2535-06-0
- Wiskostatin
Catalog No.:BCC7934
CAS No.:253449-04-6
- (+)-Corlumidine
Catalog No.:BCN2662
CAS No.:25344-54-1
- Viniferin
Catalog No.:BCN3757
CAS No.:253435-07-3
- Trazodone HCl
Catalog No.:BCC5032
CAS No.:25332-39-2
- BMS 195614
Catalog No.:BCC7740
CAS No.:253310-42-8
- Isocalamendiol
Catalog No.:BCN5119
CAS No.:25330-21-6
- Tetrabromobisphenol A diallyl ether
Catalog No.:BCC9174
CAS No.:25327-89-3
- Doxorubicin (Adriamycin) HCl
Catalog No.:BCC1117
CAS No.:25316-40-9
- Eribulin
Catalog No.:BCC5174
CAS No.:253128-41-5
- Luteosporin
Catalog No.:BCN5390
CAS No.:2530-39-4
- MRE 3008F20
Catalog No.:BCC6106
CAS No.:252979-43-4
- Litseglutine B
Catalog No.:BCN5120
CAS No.:25368-01-8
- Asperulosidic acid
Catalog No.:BCN3088
CAS No.:25368-11-0
- TRIM
Catalog No.:BCC6847
CAS No.:25371-96-4
- AR-C 102222
Catalog No.:BCC6092
CAS No.:253771-21-0
- Kanamycin Sulfate
Catalog No.:BCC1205
CAS No.:25389-94-0
- Morroniside
Catalog No.:BCN5009
CAS No.:25406-64-8
- Boc-ß-HoAsp(OBzl)-OH
Catalog No.:BCC3229
CAS No.:254101-10-5
- Phellopterin
Catalog No.:BCN2637
CAS No.:2543-94-4
- H-Cys(pMeOBzl)-OH
Catalog No.:BCC2909
CAS No.:2544-31-2
- Dehydropitavastatin ethyl ester
Catalog No.:BCC8931
CAS No.:254452-91-0
- (+)-Afzelechin
Catalog No.:BCN5121
CAS No.:2545-00-8
- Felbamate
Catalog No.:BCC4904
CAS No.:25451-15-4
New 4-thiazolidinones of nicotinic acid with 2-Amino-6-methylbenzothiazole and their biological activity.[Pubmed:21179315]
Sci Pharm. 2010 Oct-Dec;78(4):753-65.
The title compounds 6aaj, 2-[(6-methyl-1,3-benzothiazol-2-yl)amino]-N-[2-(substituted phenyl/furan-2-yl)-4-oxo-1,3-thiazolidin-3-yl]nicotinamides, were prepared from 2-chloropyridine-3-carboxylic acid (1) and 2-amino-6-methyl-benzothiazole (2) by known methods. All the compounds have been established by IR, (1)H NMR, (13)C NMR and elemental analyses. The in vitro antimicrobial screening of the compounds were carried out against two Gram positive (S. aureus, S. pyogenes), two Gram negative (E. coli, P. aeruginosa) bacteria and three fungal species (C. albicans, A. niger, A. clavatus) using the broth microdilution method. Some of the compounds are comparable with standard drugs.